White label – Pompe disease - ClinicalTrials.eu

Study on Esomeprazole Magnesium for Maintaining Healing of Erosive Esophagitis in Children Aged 1 to 11 Years

Not recruiting

3 1 1 1
Investigated Diseases:
- Erosive oesophagitis
Investigated Drugs:
- Esomeprazole Magnesium
Study Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes

Not recruiting

3 1 1 1
Investigated Diseases:
- Transitional cell carcinoma
Investigated Drugs:
Study of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
+5
Study of Tucatinib and Trastuzumab for Patients with Advanced Solid Tumors with HER2 Changes

Not recruiting

2 1 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

Not recruiting

3 1 1
Investigated Drugs:
- Niraparib Tosilate Monohydrate
- Dostarlimab
+7
Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- End stage renal disease
- Anti-neutrophil cytoplasmic antibody positive vasculitis
Investigated Drugs:
Study of Stereotactic Body Radiotherapy with or without Darolutamide for Patients with Oligorecurrent Prostate Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Darolutamide
Study on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn’s Disease, or Unclassified Inflammatory Bowel Disease

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Infliximab
Study Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Metastatic renal cell carcinoma
Investigated Drugs:
+1
Study of Nadunolimab with Gemcitabine and Carboplatin for Patients with Advanced Triple Negative Breast Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies